Pfizer has restated its commitment to develop more innovative medicines towards deepening patient-centric breakthroughs that recognises the importance of the patient in the day-to-day drug manufacturing.
“Pfizer could not realize its purpose without the pivotal role played by patients, caregive
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Seyi John Salau
Seyi John Salau is a BusinessDay Correspondent with interest in development journalism, which tells stories that connect the people, brands, and the government. SeyiJohn is also a media professional with BSc, Mass Communition (ACU); Masters of School Media (MSM, Ibadan) & MSc, Mass Communication (Caleb).
